Course Directors: William D. Freeman, M.D., Alfredo Quinones-Hinojosa, M.D., Joon H. Uhm, M.D., Betty Kim, M.D., Ph.D., Robert B. Diasio, M.D. and Asher A. Chanan-Khan, M.D.
Co-Course Directors: Christina Smith, A.R.N.P. and Suzanne Brown, B.S.N., C.N.R.N., S.C.R.N.
This course will provide attendees with an update in major areas of neuroscience and oncology research from basic science, translational laboratories and clinical trials research. Lectures will cover neuroscientific arenas including brain tumor biology and growth, vascular neogenesis, nanotechnology for tumor suppression, viral vectors for tumor destruction, and other new agents to target and destroy brain tumors. The conference will discuss basic tumors of the brain and other sites including breast in addition to metastatic brain tumor therapies. Also, the course will cover the latest diagnostic and therapeutic approaches to tumors. Lectures will be supplemented with high yield industry and CEO-level Q&A sessions, precision medicine, and patient and celebrity stories. Other high yield sessions will include governmental policy makers that are guiding brain tumor patient care for future health care systems.
On or Before
August 7, 2017
August 7, 2017
Physicians and Scientists
|ARNPs & PAs, Residents, Fellows, RNs, Allied Health and Retirees||$400||$500|
Public/Student (No CEUs or CMEs Awarded)*
*If you are not claiming continuing education credits, please contact the CME Department at 1-800-462-9633 to register by phone.
|$50 per day||$50 per day|
Program Agenda (PDF)
Course Brochure (PDF)
This course offers the unique opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibit space during this course, please contact Florida Exhibits.